DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,585 | -7.8% | 21,351 | +2.0% | 0.00% | – |
| Q2 2023 | $294,666 | +1.8% | 20,928 | +11.7% | 0.00% | – |
| Q1 2023 | $289,440 | +2.0% | 18,734 | +8.3% | 0.00% | – |
| Q4 2022 | $283,629 | -11.4% | 17,305 | 0.0% | 0.00% | – |
| Q3 2022 | $320,143 | +40.4% | 17,305 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $228,000 | +51.0% | 17,305 | +5.7% | 0.00% | – |
| Q1 2022 | $151,000 | +7.1% | 16,365 | +13.4% | 0.00% | – |
| Q4 2021 | $141,000 | -79.4% | 14,431 | -28.3% | 0.00% | -100.0% |
| Q3 2021 | $685,000 | -6.5% | 20,139 | +0.6% | 0.00% | 0.0% |
| Q2 2021 | $733,000 | -19.4% | 20,020 | -1.2% | 0.00% | -50.0% |
| Q1 2021 | $909,000 | -15.0% | 20,262 | +8.1% | 0.00% | 0.0% |
| Q4 2020 | $1,069,000 | +40.3% | 18,737 | +26.1% | 0.00% | 0.0% |
| Q3 2020 | $762,000 | -1.3% | 14,858 | +15.0% | 0.00% | 0.0% |
| Q2 2020 | $772,000 | +82.1% | 12,920 | +25.5% | 0.00% | +100.0% |
| Q1 2020 | $424,000 | -29.2% | 10,298 | +7.0% | 0.00% | 0.0% |
| Q4 2019 | $599,000 | +154.9% | 9,626 | +39.0% | 0.00% | 0.0% |
| Q3 2019 | $235,000 | – | 6,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |